The preliminary study on effect of targeting drugs on human non-small cell lung cancer A549 cells in vitro and quantification of iodine with Gemstone Spectral Imaging

詹爽,赵小英,汪琛玮,吴兴旺

DOI: https://doi.org/10.19405/j.cnki.issn1000-1492.2018.06.024

2018-01-01

Abstract:Objective To explore the effects of targeting drug on human non-small cell lung cancer A549 cells in vitro and quantification of iodine with gemstone spectral imaging(GSI). Methods In the first part, synthesis of small iodine-containing drugs with cytotoxicity targeting A549 cells. A549 cells were treated in vitro with targeting drugs and gefitinib at a concentration gradient of 2.5,5,10,20,40 μmol/L. Their proliferation effects were ana-lyzed by the thiazolyl blue ( MTT) assay. In the second part, targeting drugs and gefitinib at a concentration gradi-ent of 0,1.87,3.75,7.5,15,30 mmol/L underwent GE HD750 CT with GSI mode. Analyzing the inhibition rate of two kinds of drug cell proliferation ,comparing the relation and discrepancy between measured iodine concentrations and real iodine concentrations. Results In the first part, Targeting drugs and gefitinib induced a dose-and time-independent growth inhibition by MTT. When the concentration was more than 10 μmol/L, the inhibitory rate of targeting drugs was higher than that of gefitinib (P＜0.05). In the second part, in a certain range of concentration, the CT value and iodine concentration of targeting drugs were significantly higher than that of gefitinib(P＜0.05). The measured concentrations of targeting drugs were obviously correlated to the real concentrations ( r =0.998 ) without significant difference between these two values(P＞0.05). Conclusion The targeting drug has good in-hibitory effect on A549 cells in vitro. The high CT value of targeting drugs is good for CT shows. GSI of spectral CT is a reliable method to quantify iodine of the targeting drugs.